Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pyxis Oncology (PYXS) Other Operating Expenses (2024)

Historic Other Operating Expenses for Pyxis Oncology (PYXS) over the last 1 years, with Q4 2024 value amounting to $21.0 million.

  • Pyxis Oncology's Other Operating Expenses changed N/A to $21.0 million in Q4 2024 from the same period last year, while for Sep 2025 it was $21.0 million, marking a year-over-year change of. This contributed to the annual value of $21.4 million for FY2024, which is 7807.87% down from last year.
  • Pyxis Oncology's Other Operating Expenses amounted to $21.0 million in Q4 2024.
  • Over the past 5 years, Pyxis Oncology's Other Operating Expenses peaked at $21.0 million during Q4 2024, and registered a low of $475000.0 during Q1 2024.